ATLANTA, GA - Iconic Therapeutics Inc. has raised $2.57 million of a $4.2 million C round, according to Dow Jones’ VentureWire. (more…)

Raleigh, NC – Arbor Pharmaceuticals (“Arbor”), an emerging specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company recently closed its Series A financing. This latest round of investment capital will support the launch of Arbor’s third product and facilitate continued growth of the company and its current and pipeline products. The Series A funding was participated in by several new investors in addition to the company’s original investment group. Since the founding of Arbor in 2006 the company has launched two novel prescription products for ear infections (Zinotic® and Neotic®) and is developing a pipeline of unique nonantibiotic products for common pediatric illnesses. (more…)